HEART FAILURE NYHA CLASS III
Clinical trials for HEART FAILURE NYHA CLASS III explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE NYHA CLASS III trials appear
Sign up with your email to follow new studies for HEART FAILURE NYHA CLASS III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a phone call a week keep heart failure at bay?
Disease control Recruiting nowThis study tests a 12-week phone coaching program for 280 adults with mild-to-moderate heart failure. The program uses positive psychology and motivational interviewing to help patients improve their diet, exercise, and medication habits. Participants also receive text messages f…
Matched conditions: HEART FAILURE NYHA CLASS III
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 17, 2026 00:30 UTC
-
Heart failure patients get High-Tech help: two devices aim to ease symptoms
Disease control Recruiting nowThis study tests two devices in people with advanced heart failure. The CardioMems monitors pressure in the lungs, and the BaroStim stimulates nerves to improve heart function. Researchers will track changes in symptoms, walking ability, and hospital visits over a year. The goal …
Matched conditions: HEART FAILURE NYHA CLASS III
Phase: PHASE2, PHASE3 • Sponsor: Northwell Health • Aim: Disease control
Last updated May 17, 2026 00:29 UTC
-
Smart watch for the heart: new AI aims to slash heart failure deaths
Disease control Recruiting nowThis study tests a new remote monitoring system called SmartSignalHF for people with heart failure who have a pacemaker or defibrillator. The goal is to see if it can reduce deaths and hospitalizations compared to standard care. About 1,132 adults with moderate heart failure will…
Matched conditions: HEART FAILURE NYHA CLASS III
Phase: NA • Sponsor: Implicity • Aim: Disease control
Last updated May 17, 2026 00:28 UTC
-
Lab-grown heart cells tested in humans for first time
Disease control Recruiting nowThis early-stage trial tests whether heart cells grown from a patient's own stem cells are safe to inject into people with severe congenital heart disease. About 50 participants will receive the cells or be in a comparison group. The main goal is to check for serious side effects…
Matched conditions: HEART FAILURE NYHA CLASS III
Phase: PHASE1 • Sponsor: HeartWorks, Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Heart failure patients may get a High-Tech lifeline: a sensor that monitors pressure in the lungs
Disease control Recruiting nowThis study looks at whether a small sensor placed in the lung artery (the Cordella PA Sensor System) can help people with chronic heart failure by reducing deaths and hospital stays. About 2,150 people will be tracked for two years, comparing those who get the sensor to those who…
Matched conditions: HEART FAILURE NYHA CLASS III
Sponsor: Endotronix, Inc. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New sensor aims to keep heart failure patients out of the hospital
Disease control Recruiting nowThis study tests a small sensor placed in the lung artery to monitor heart pressure in people with heart failure. The sensor sends daily readings to doctors, helping them adjust treatment early to prevent worsening symptoms. About 1,750 adults with mild to moderate heart failure …
Matched conditions: HEART FAILURE NYHA CLASS III
Phase: NA • Sponsor: Endotronix, Inc. • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New study brings palliative care to rural heart failure Patients' doorsteps
Symptom relief Recruiting nowThis study tests a nurse-led home care program for people with advanced heart failure and their family caregivers in rural Appalachia. The program uses faith-based nurses and local volunteers to improve quality of life and reduce symptoms. About 208 patients and their caregivers …
Matched conditions: HEART FAILURE NYHA CLASS III
Phase: NA • Sponsor: West Virginia University • Aim: Symptom relief
Last updated May 14, 2026 12:03 UTC
-
No-Implant heart shunt could ease failure symptoms
Symptom relief Recruiting nowThis early study tests a device that creates a small opening between the upper chambers of the heart to relieve pressure and improve symptoms in people with heart failure. About 20 adults with moderate to severe heart failure will receive the procedure. The main goal is to check …
Matched conditions: HEART FAILURE NYHA CLASS III
Phase: NA • Sponsor: InterShunt Technologies, Inc. • Aim: Symptom relief
Last updated May 13, 2026 16:00 UTC